Related Experiment Video

Updated: Jun 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Update on antithrombotic therapy for stroke prevention in atrial fibrillation

Hermelinda G Abcede1, Bruce Ovbiagele

  • 1Department of Neurology, University of California, Los Angeles, 710 Westwood Plaza, Suite 1-240, Los Angeles, CA 90095 USA.

Current Treatment Options in Cardiovascular Medicine
|May 13, 2010
PubMed

Insights

Atrial fibrillation (AF) increases stroke risk in older adults. Combination antiplatelet therapy shows promise as an alternative to warfarin for stroke prevention in high-risk AF patients.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Atrial fibrillation (AF) is a common cardiac arrhythmia in the elderly, significantly increasing stroke risk.
  • Strokes associated with AF are often severe and fatal, necessitating effective preventative strategies.
  • Warfarin is a recognized effective treatment for stroke prevention in high-risk AF patients, but concerns limit its use.

Purpose of the Study:

  • To review the efficacy of combination antiplatelet regimens for stroke prevention in patients with nonvalvular AF.
  • To compare combination antiplatelet therapy with other antithrombotic strategies, including warfarin, single antiplatelet therapy, and newer agents.

Main Methods:

  • Review of two recent clinical trials investigating combination antiplatelet regimens in high-risk nonvalvular AF patients.
  • Discussion of existing literature on oral anticoagulation, single antiplatelet therapies, and novel anticoagulants (direct thrombin inhibitors, factor Xa inhibitors).

Main Results:

  • Combination antiplatelet regimens were investigated as an alternative to warfarin for stroke prevention.
  • The article evaluates the potential of these regimens to match or exceed warfarin's efficacy with a more favorable side effect profile.

Conclusions:

  • Combination antiplatelet therapy is explored as a viable option for stroke prevention in specific AF patient populations.
  • Further research and clinical trials are essential to establish the role of novel antithrombotic therapies in managing AF-related stroke risk.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...